TY - JOUR
T1 - Immunophenotypic patterns and cytogenetic anomalies in acute non-lymphoblastic leukemia subtypes
T2 - A prospective study of 432 patients
AU - Casasnovas, R. O.
AU - Campos, L.
AU - Mugneret, F.
AU - Charrin, C.
AU - Béné, M. C.
AU - Garand, R.
AU - Favre, M.
AU - Sartiaux, C.
AU - Chaumarel, I.
AU - Bernier, M.
AU - Faure, G.
AU - Solary, E.
N1 - Funding Information:
The GEIL is Réseau INSERM and is supported by a grant from the Association pour la Recherche contre le Cancer. The GEIL includes: J Gardais, M Dautel (Angers); J Feuillard, M Raphael (Bobigny); G Lecalvez, MC Léglise (Brest); V Deneys, AM Mazzon (Bruxelles-UCL); M Bernier (Bruxelles Bordet); AM Malet, C Salaun (Caen); P Bourin (Clamart); H Jouault (Creteil-Mondor); F Lelong, P Chrétien (Créteil-CHIC); E Solary, RO Casasnovas, M Maynadié, P Mostovtchenko (Dijon); M Favre, MC Jacob, JC Bensa (Grenoble); G Wallef (La Haine St Paul); C Sartiaux (Lille); L Campos, O Sabido, C Vasselon, D Guyotat (St-Etienne); C Brunet, P Poncelet, AM Guitard (Marseille); J Taib, T Lavabre Bertrand, C Lavabre-Bertrand (Montpellier); G Jung, G Kandel (Mulhouse); R Garand, N Robillard (Nantes); P Philip, I Sudaka, F Monpoux, D Vanhaecke, A Bernard (Nice); JY Perrot, JP Marie (Paris Hotel Dieu); F Valensi (Paris Necker); V Vergé, JC Homberg (Paris St Antoine); G Schaison, L Boumsell (Paris St Louis); H Firat, L Douay (Paris Trousseau); T Samson (Paris Val De Grace); S Daliphard (Reims); B Drenou, R Fauchet (Rennes); O Lees, B Lenormand, JP Vann-ier (Rouen); A Flakenrodt, A Albert (Strasbourg); E Kuhlein (Toulouse); MH Estienne, JL Bremond, M Degenne (Tours); F Le Baron, G Reumaux, P Duthilleul (Valenciennes); MC Béné, GC Faure, MN Kolopp-Sarda, P Bordigoni, F Witz (Vandoeuvre Les Nancy); C Bayle, J Antonini (Villejuif IGR); C Boucheix, A Charpentier (Villejuif P Brousse). The karyotypes were performed by: MF Bertheas (St-Etienne), C Charrin (Lyon), JL Lai (Lille), F Mugneret (Dijon), MJ Grégoire (Nancy), E Pluchon-Rivière (Brest), P Talmain (Nantes).
PY - 1998/1/1
Y1 - 1998/1/1
N2 - This study prospectively analysed the relationships between immunophenotypic and cytogenetic features of blast cells in 432 acute non-lymphoblastic leukemias (ANLL) at presentation. An abnormal karyotype was detected in 232 cases (54%). These abnormalities were related to immunophenotypic markers as detected using a consensual panel of monoclonal antibodies allowing lineage assignment and investigation of myeloid marker expression on blast cells. In univariate analysis, CD9, CD10, CD15, CD34 and TdT expression appeared significantly associated with chromosomal anomalies. Multivariate analysis identified CD34 and CD9 expression as independently predictive of the presence of at least one cytogenetic abnormality (P < 10-4 and P < 0.03, respectively). Significant associations between immunophenotypic and karyotypic features were observed both within individual FAB subgroups and independently from morphological criteria. Specific features were seen in five ANLL entities: M0 or M1/B lineage antigen positivity/t(9;22) or del(11)(q23); M2/CD13-/t(8;21); M4/CD13+, CD34+, CD36+/inv(16); M4 or M5/lack of B lineage antigen/del(11)(q23) or t(9;11). More practically, and although the relationships demonstrated only represent a fraction of homogeneous immunophenotypic subgroups, identification of such immunophenotypic features should prompt careful karyotypic examination, eventually using molecular biology analysis on non-growing cells.
AB - This study prospectively analysed the relationships between immunophenotypic and cytogenetic features of blast cells in 432 acute non-lymphoblastic leukemias (ANLL) at presentation. An abnormal karyotype was detected in 232 cases (54%). These abnormalities were related to immunophenotypic markers as detected using a consensual panel of monoclonal antibodies allowing lineage assignment and investigation of myeloid marker expression on blast cells. In univariate analysis, CD9, CD10, CD15, CD34 and TdT expression appeared significantly associated with chromosomal anomalies. Multivariate analysis identified CD34 and CD9 expression as independently predictive of the presence of at least one cytogenetic abnormality (P < 10-4 and P < 0.03, respectively). Significant associations between immunophenotypic and karyotypic features were observed both within individual FAB subgroups and independently from morphological criteria. Specific features were seen in five ANLL entities: M0 or M1/B lineage antigen positivity/t(9;22) or del(11)(q23); M2/CD13-/t(8;21); M4/CD13+, CD34+, CD36+/inv(16); M4 or M5/lack of B lineage antigen/del(11)(q23) or t(9;11). More practically, and although the relationships demonstrated only represent a fraction of homogeneous immunophenotypic subgroups, identification of such immunophenotypic features should prompt careful karyotypic examination, eventually using molecular biology analysis on non-growing cells.
KW - Acute non-lymphoblastic leukemia
KW - Chromosome abnormalities
KW - Immunophenotype
UR - http://www.scopus.com/inward/record.url?scp=17344393858&partnerID=8YFLogxK
U2 - 10.1038/sj.leu.2400893
DO - 10.1038/sj.leu.2400893
M3 - Article
C2 - 9436918
AN - SCOPUS:17344393858
SN - 0887-6924
VL - 12
SP - 34
EP - 43
JO - Leukemia
JF - Leukemia
IS - 1
ER -